Home
Project
Partners
Impact
Resources
- Leaflet
- Videos
Contact
News

Events

Filter by
Categories
Tags
Authors
Show all

All
Document
Events
News
Publications
Uncategorized
Vacancies

All

All
Martijn
Anita Ordas

May 2, 2022

IPIC5 Congress

Do you like it?19

February 28, 2022

Today it’s Rare disease day

Do you like it?18

February 8, 2022

Mini-symposium “Breaking the Bubble”

Do you like it?17

May 18, 2021

Successful Recomb Review meeting

Do you like it?20

Search

Blog

On this page you can find all the news and updates about the RECOMB project.

Categories

Document
Events
News
Publications
Uncategorized
Vacancies

Latest comments

February 3, 2022
Rhiannon Lowe commented on Obituary Dr. Manfred Schmidt
January 20, 2021
Magda Lourenço commented on RECOMB Webinar: GENE THERAPY for RAG1-SCID

Meta

Log in
Entries feed
Comments feed
WordPress.org

About us

The RECOMB consortium brings together a large number of clinical and research professionals from 16 European and 1 Israeli institutes with expertise in the management of primary immunodeficiencies, such as SCID.

Our mission

The ultimate aim of RECOMB is to create a treatment for the most common type of SCID, RAG1-SCID by performing phase 1 and phase 2 clinical trials using autologous haematopoietic stem cell‒based gene therapy.

Useful links

Learn more about Primary immunodeficiencies
Learn more about SCID
Learn more about Gene Therapy

This project has received funding from the European Union’s Horizon 2020 research and
innovation programme under grant agreement n° 755170’

© 2023 RECOMB. All Rights Reserved. Muffin group